Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does INTERFERON BETA-1B Cause Injection site rash? 129 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 129 reports of Injection site rash have been filed in association with INTERFERON BETA-1B (Betaseron). This represents 1.1% of all adverse event reports for INTERFERON BETA-1B.

129
Reports of Injection site rash with INTERFERON BETA-1B
1.1%
of all INTERFERON BETA-1B reports
0
Deaths
20
Hospitalizations

How Dangerous Is Injection site rash From INTERFERON BETA-1B?

Of the 129 reports, 20 (15.5%) required hospitalization.

Is Injection site rash Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for INTERFERON BETA-1B. However, 129 reports have been filed with the FAERS database.

What Other Side Effects Does INTERFERON BETA-1B Cause?

Multiple sclerosis relapse (1,229) Influenza like illness (1,042) Injection site pain (1,014) Fatigue (783) Drug ineffective (767) Injection site erythema (724) Injection site reaction (707) Pain (597) Headache (596) Multiple sclerosis (589)

What Other Drugs Cause Injection site rash?

ETANERCEPT (3,781) DUPILUMAB (3,566) ADALIMUMAB (2,108) TIRZEPATIDE (1,131) IXEKIZUMAB (526) DULAGLUTIDE (501) EVOLOCUMAB (465) TERIPARATIDE (426) SARILUMAB (424) HYDROXYPROGESTERONE CAPROATE (384)

Which INTERFERON BETA-1B Alternatives Have Lower Injection site rash Risk?

INTERFERON BETA-1B vs INTERFERON GAMMA INTERFERON BETA-1B vs INTERFERON GAMMA-1B INTERFERON BETA-1B vs INVEGA INTERFERON BETA-1B vs INVEGA SUSTENNA INTERFERON BETA-1B vs INVESTIGATIONAL BIOSIMILARS

Related Pages

INTERFERON BETA-1B Full Profile All Injection site rash Reports All Drugs Causing Injection site rash INTERFERON BETA-1B Demographics